124 related articles for article (PubMed ID: 15619397)
1. Usefulness of C-reactive protein as an independent predictor of death in patients with ischemic cardiomyopathy.
Chirinos JA; Zambrano JP; Chakko S; Schob A; Veerani A; Perez GO; Mendez AJ
Am J Cardiol; 2005 Jan; 95(1):88-90. PubMed ID: 15619397
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
[TBL] [Abstract][Full Text] [Related]
3. Circulating erythropoietin levels and prognosis in patients with congestive heart failure: comparison with neurohormonal and inflammatory markers.
George J; Patal S; Wexler D; Abashidze A; Shmilovich H; Barak T; Sheps D; Keren G
Arch Intern Med; 2005 Jun; 165(11):1304-9. PubMed ID: 15956012
[TBL] [Abstract][Full Text] [Related]
4. Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study.
Bellocci F; Biasucci LM; Gensini GF; Padeletti L; Raviele A; Santini M; Giubilato G; Landolina M; Biondi-Zoccai G; Raciti G; Sassara M; Castro A; Kheir A; Crea F
J Cardiovasc Med (Hagerstown); 2007 Apr; 8(4):293-9. PubMed ID: 17413310
[TBL] [Abstract][Full Text] [Related]
5. Preoperative C-reactive protein levels predict 9-month mortality after coronary artery bypass grafting surgery for the treatment of left main coronary artery stenosis.
Palmerini T; Marzocchi A; Marrozzini C; Reggiani LB; Savini C; Marinelli G; Di Bartolomeo R; Branzi A
Eur J Cardiothorac Surg; 2007 Apr; 31(4):685-90. PubMed ID: 17236785
[TBL] [Abstract][Full Text] [Related]
6. Effect of myocardial ischemia during dobutamine stress echocardiography on cardiac mortality in patients with heart failure secondary to ischemic cardiomyopathy.
Elhendy A; Sozzi F; van Domburg RT; Bax JJ; Schinkel AF; Roelandt JR; Poldermans D
Am J Cardiol; 2005 Aug; 96(4):469-73. PubMed ID: 16098295
[TBL] [Abstract][Full Text] [Related]
7. Preoperative C-reactive protein levels to predict early and late mortalities after coronary artery bypass surgery: eight years of follow-up.
van Straten AH; Soliman Hamad MA; van Zundert AJ; Martens EJ; Schönberger JP; de Wolf AM
J Thorac Cardiovasc Surg; 2009 Oct; 138(4):954-8. PubMed ID: 19660390
[TBL] [Abstract][Full Text] [Related]
8. Preoperative C-reactive protein is predictive of long-term outcome after coronary artery bypass surgery.
Kangasniemi OP; Biancari F; Luukkonen J; Vuorisalo S; Satta J; Pokela R; Juvonen T
Eur J Cardiothorac Surg; 2006 Jun; 29(6):983-5. PubMed ID: 16682213
[TBL] [Abstract][Full Text] [Related]
9. High-sensitivity C-reactive protein: potential adjunct for risk stratification in patients with stable congestive heart failure.
Lamblin N; Mouquet F; Hennache B; Dagorn J; Susen S; Bauters C; de Groote P
Eur Heart J; 2005 Nov; 26(21):2245-50. PubMed ID: 16183690
[TBL] [Abstract][Full Text] [Related]
10. C-reactive protein predicts death in patients with non-ischemic cardiomyopathy.
Ronnow BS; Reyna SP; Muhlestein JB; Horne BD; Allen Maycock CA; Bair TL; Carlquist JF; Kfoury AG; Anderson JL; Renlund DG;
Cardiology; 2005; 104(4):196-201. PubMed ID: 16155394
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of preoperative C-reactive protein and soluble intercellular adhesion molecule-1 level for predicting future cardiovascular events after coronary artery bypass grafting.
van der Harst P; Voors AA; Volbeda M; Buikema H; van Veldhuisen DJ; van Gilst WH
Am J Cardiol; 2006 Jun; 97(12):1697-701. PubMed ID: 16765116
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of combining serum uric acid and C-reactive protein for risk stratification of patients with coronary artery disease (Bezafibrate Infarction Prevention [BIP] study).
Brodov Y; Behar S; Goldenberg I; Boyko V; Chouraqui P
Am J Cardiol; 2009 Jul; 104(2):194-8. PubMed ID: 19576345
[TBL] [Abstract][Full Text] [Related]
13. Comparison of usefulness of C-reactive protein versus white blood cell count to predict outcome after primary percutaneous coronary intervention for ST elevation myocardial infarction.
Smit JJ; Ottervanger JP; Slingerland RJ; Kolkman JJ; Suryapranata H; Hoorntje JC; Dambrink JH; Gosselink AT; de Boer MJ; Zijlstra F; van 't Hof AW;
Am J Cardiol; 2008 Feb; 101(4):446-51. PubMed ID: 18312755
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of elevated neutrophil-lymphocyte ratio on cardiac mortality in patients with stable coronary artery disease.
Papa A; Emdin M; Passino C; Michelassi C; Battaglia D; Cocci F
Clin Chim Acta; 2008 Sep; 395(1-2):27-31. PubMed ID: 18498767
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of serum high-density lipoprotein cholesterol level as an independent predictor of one-year mortality after percutaneous coronary interventions.
Ghazzal ZB; Dhawan SS; Sheikh A; Douglas JS; Veledar E; Mavromatis K; Pohlel FK; Vaccarino V
Am J Cardiol; 2009 Apr; 103(7):902-6. PubMed ID: 19327413
[TBL] [Abstract][Full Text] [Related]
16. [Correlation of high-sensitivity CRP concentration with the extent of coronary atherosclerosis in men with symptoms of ischemic heart disease].
Piechota W; Piechota W
Pol Merkur Lekarski; 2005 May; 18(107):511-5. PubMed ID: 16161944
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of elevations in serum choline and free F2)-isoprostane to predict 30-day cardiovascular outcomes in patients with acute coronary syndrome.
LeLeiko RM; Vaccari CS; Sola S; Merchant N; Nagamia SH; Thoenes M; Khan BV
Am J Cardiol; 2009 Sep; 104(5):638-43. PubMed ID: 19699337
[TBL] [Abstract][Full Text] [Related]
18. High levels of C-reactive protein with low total cholesterol concentrations additively predict all-cause mortality in patients with coronary artery disease.
Jánoskuti L; Förhécz Z; Hosszúfalusi N; Kleiber M; Walentin S; Bálint O; Duba J; Rugonfalvi-Kiss S; Romics L; Karádi I; Füst G; Prohászka Z
Eur J Clin Invest; 2005 Feb; 35(2):104-11. PubMed ID: 15667581
[TBL] [Abstract][Full Text] [Related]
19. Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease.
Richards M; Nicholls MG; Espiner EA; Lainchbury JG; Troughton RW; Elliott J; Frampton CM; Crozier IG; Yandle TG; Doughty R; MacMahon S; Sharpe N; ;
J Am Coll Cardiol; 2006 Jan; 47(1):52-60. PubMed ID: 16386664
[TBL] [Abstract][Full Text] [Related]
20. C-reactive protein predicts long-term mortality independently of low-density lipoprotein cholesterol in patients undergoing percutaneous coronary intervention.
Razzouk L; Muntner P; Bansilal S; Kini AS; Aneja A; Mozes J; Ivan O; Jakkula M; Sharma S; Farkouh ME
Am Heart J; 2009 Aug; 158(2):277-83. PubMed ID: 19619706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
